6ZN8 image
Deposition Date 2020-07-06
Release Date 2020-11-04
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6ZN8
Keywords:
Title:
Crystal structure of the H. influenzae VapXD toxin-antitoxin complex
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.21 Å
R-Value Free:
0.29
R-Value Work:
0.25
R-Value Observed:
0.26
Space Group:
I 41 3 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Endoribonuclease VapD
Gene (Uniprot):vapD
Chain IDs:A, B, C (auth: D), D (auth: E)
Chain Length:100
Number of Molecules:4
Biological Source:Haemophilus influenzae (strain 86-028NP)
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:VapX
Gene (Uniprot):vapX
Chain IDs:E (auth: C), F
Chain Length:81
Number of Molecules:2
Biological Source:Haemophilus influenzae (strain 86-028NP)
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET modified residue
Ligand Molecules
Primary Citation
Structural Basis for Toxin Inhibition in the VapXD Toxin-Antitoxin System.
Structure 29 139 ? (2021)
PMID: 33096014 DOI: 10.1016/j.str.2020.10.002

Abstact

Bacterial type II toxin-antitoxin (TA) modules encode a toxic protein that downregulates metabolism and a specific antitoxin that binds and inhibits the toxin during normal growth. In non-typeable Haemophilus influenzae, a common cause of infections in humans, the vapXD locus was found to constitute a functional TA module and contribute to pathogenicity; however, the mode of action of VapD and the mechanism of inhibition by the VapX antitoxin remain unknown. Here, we report the structure of the intact H. influenzae VapXD complex, revealing an unusual 2:1 TA molecular stoichiometry where a Cas2-like homodimer of VapD binds a single VapX antitoxin. VapX consists of an oligonucleotide/oligosaccharide-binding domain that docks into an asymmetrical cavity on the toxin dimer. Structures of isolated VapD further reveal how a symmetrical toxin homodimer adapts to interacting with an asymmetrical antitoxin and suggest how a primordial TA system evolved to become part of CRISPR-Cas immunity systems.

Legend

Protein

Chemical

Disease

Primary Citation of related structures